Drug interaction study completed: Carbamazepine's impact on nerandomilast revealed
NCT ID NCT07100964
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 26 times
Summary
This completed Phase 1 trial in 16 healthy men tested whether taking carbamazepine (a seizure medicine) changes how the body absorbs and processes nerandomilast, an experimental drug for lung fibrosis. Participants received a single dose of nerandomilast with and without multiple doses of carbamazepine. The study measured drug levels in the blood to check for interactions, helping guide future dosing recommendations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.